These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6271833)

  • 21. Stereochemical requirements for cannabinoid activity.
    Mechoulam R; Lander N; Varkony TH; Kimmel I; Becker O; Ben-Zvi Z; Edery H; Porath G
    J Med Chem; 1980 Oct; 23(10):1068-72. PubMed ID: 7420350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
    Compton DR; Johnson MR; Melvin LS; Martin BR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):201-9. PubMed ID: 1309872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC.
    Martin BR; Compton DR; Semus SF; Lin S; Marciniak G; Grzybowska J; Charalambous A; Makriyannis A
    Pharmacol Biochem Behav; 1993 Oct; 46(2):295-301. PubMed ID: 8265683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships of indole- and pyrrole-derived cannabinoids.
    Wiley JL; Compton DR; Dai D; Lainton JA; Phillips M; Huffman JW; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):995-1004. PubMed ID: 9618400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
    Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
    Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid induced degranulation of rabbit neutrophils.
    Naccache PH; Volpi M; Becker EL; Makryannis A; Sha'afi RI
    Biochem Biophys Res Commun; 1982 Jun; 106(4):1286-90. PubMed ID: 6288043
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of cannabinoids and their antiemetic effectiveness.
    Vincent BJ; McQuiston DJ; Einhorn LH; Nagy CM; Brames MJ
    Drugs; 1983 Feb; 25 Suppl 1():52-62. PubMed ID: 6301800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure--activity studies on tetrahydro- and hexahydrocannabinol derivatives.
    Skinner WA; Rackur G; Uyeno E
    J Pharm Sci; 1979 Mar; 68(3):330-2. PubMed ID: 423121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol.
    Davis WM; Hatoum NS
    Gen Pharmacol; 1983; 14(2):247-52. PubMed ID: 6301931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levonantradol-induced inhibition of acetylcholine turnover in rat hippocampus and striatum.
    Costa E; Cheney DL; Murray TF
    J Clin Pharmacol; 1981; 21(S1):256S-261S. PubMed ID: 6271831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
    Compton DR; Prescott WR; Martin BR; Siegel C; Gordon PM; Razdan RK
    J Med Chem; 1991 Nov; 34(11):3310-6. PubMed ID: 1659638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists.
    Wiley JL; Beletskaya ID; Ng EW; Dai Z; Crocker PJ; Mahadevan A; Razdan RK; Martin BR
    J Pharmacol Exp Ther; 2002 May; 301(2):679-89. PubMed ID: 11961073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of cannabinoid compounds to stimulate estrogen receptors.
    Ruh MF; Taylor JA; Howlett AC; Welshons WV
    Biochem Pharmacol; 1997 Jan; 53(1):35-41. PubMed ID: 8960061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic cannabinoids: the hidden side of Spice drugs.
    Pintori N; Loi B; Mereu M
    Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity.
    Meschler JP; Conley TJ; Howlett AC
    Pharmacol Biochem Behav; 2000 Nov; 67(3):567-73. PubMed ID: 11164087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs.
    Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR
    J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
    Little PJ; Compton DR; Johnson MR; Melvin LS; Martin BR
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1046-51. PubMed ID: 2849657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabimimetic activity (delta 1-THC cue) of cannabidiol monomethyl ether and two stereoisomeric hexahydrocannabinols in rats and pigeons.
    Järbe TU; Hiltunen AJ; Lander N; Mechoulam R
    Pharmacol Biochem Behav; 1986 Aug; 25(2):393-9. PubMed ID: 3020594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
    Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
    Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.
    Thomas BF; Adams IB; Mascarella SW; Martin BR; Razdan RK
    J Med Chem; 1996 Jan; 39(2):471-9. PubMed ID: 8558515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.